ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

December 27, 2002

Sieving Named Director, National Eye Insitute.

January 19, 2001

NCI Considering Proposal To Form “Drug Discovery Cooperative Groups”; Concept To DCT Board In June

February 26, 1982

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988